Advocacy intelligence hub — real-time data for patient organizations
Tzield: FDA approved
to delay the onset of Stage 3 type 1 diabetes in adults and pediatric patients 8 years of age and older with Stage 2 type 1 diabetes
Data from FDA regulatory filings and ClinicalTrials.gov. Updated periodically.
FINANCIAL LANDSCAPE SUMMARY
Total programs
Browse all Early-onset obesity-hyperphagia-severe developmental delay syndrome news →
View all Early-onset obesity-hyperphagia-severe developmental delay syndrome specialists →